Overview

A Study of Naldemedine (S-297995) for the Treatment of Opioid-Induced Constipation in Adults With Non-Malignant Chronic Pain Receiving Opioid Therapy

Status:
Completed

Trial end date:
2012-08-22

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine efficacy and safety of naldemedine for the treatment of opioid-induced constipation in adults with non-malignant chronic pain receiving opioid therapy for ≥ 3 months.

Phase:

Phase 2

Details

Lead Sponsor:

Shionogi

Treatments:

Analgesics, Opioid